NBP
NovaBridge Biosciences
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- NovaBridge Biosciences received FDA Fast Track designation for Givastomig in first-line HER2-negative metastatic gastric cancerJun 16, 2026
- NovaBridge reported a productive FDA Type B meeting regarding a potential accelerated approval pathway for Givastomig in gastric cancerMar 16, 2026
- NovaBridge presents positive Givastomig dose‑expansion data from Phase 1b combination study in first‑line metastatic gastric cancerJan 6, 2026